Ching Boon Chye, Tan Hui Shan, Tan Puay Hoon, Toh Chee Keong, Kanesvaran Ravindran, Ng Quan Sing, Tan Min Han
Department of Diagnostic Radiology, Singapore General Hospital, Singapore.
Division of Medical Oncology, National Cancer Centre Singapore, Singapore.
Singapore Med J. 2017 May;58(5):262-266. doi: 10.11622/smedj.2016081. Epub 2016 Apr 19.
This study analysed the tumour attenuation characteristics of different subtypes of renal cell carcinomas (RCCs), including clear cell RCC (ccRCC), papillary RCC (pRCC), mixed RCC, chromophobe RCC (chRCC) and oncocytoma.
We randomly selected 100 RCC cases that underwent nephrectomy between 2004 and 2012 from a collaborative database. Of these cases, 36 were excluded due to the absence of available imaging. The remaining 64 cases comprised 35 ccRCCs, 11 pRCCs, eight chRCCs, seven mixed RCCs and three oncocytomas. The cases were classified as computed tomography (CT) kidney, CT urogram (with plain, nephrographic and pyelographic phases) or CT abdomen (with portovenous and delayed phases). A circular region of interest (ROI) ≥ 1 cm was drawn and the same standard ROI size was used for each phase at the same site; three different circular ROIs were drawn per lesion per phase. Analysis of variance and t-test were used to examine differences in the radiological characteristics.
There was no statistical difference in the attenuation and degree of enhancement between mixed RCCs and ccRCCs. The attenuation and degree of enhancement of the oncocytomas were significantly higher than those of the other RCC subtypes.
While mixed RCCs did not have attenuation characteristics that differed significantly from those of ccRCCs, oncocytomas can be distinguished from ccRCCs, pRCCs, chRCCs and mixed RCCs by their high radiological density and enhancement. The ability to differentiate oncocytomas from these tumours potentially allows the preoperative selection of patients with small renal masses for conservative management.
本研究分析了不同亚型肾细胞癌(RCC)的肿瘤衰减特征,包括透明细胞RCC(ccRCC)、乳头状RCC(pRCC)、混合性RCC、嫌色细胞RCC(chRCC)和嗜酸细胞瘤。
我们从一个合作数据库中随机选取了2004年至2012年间接受肾切除术的100例RCC病例。其中,36例因缺乏可用影像而被排除。其余64例包括35例ccRCC、11例pRCC、8例chRCC、7例混合性RCC和3例嗜酸细胞瘤。这些病例被分类为计算机断层扫描(CT)肾脏、CT尿路造影(包括平扫、肾实质期和肾盂期)或CT腹部(包括门静脉期和延迟期)。绘制一个直径≥1 cm的圆形感兴趣区(ROI),并在同一部位的每个阶段使用相同标准的ROI大小;每个病变每个阶段绘制三个不同的圆形ROI。采用方差分析和t检验来检验放射学特征的差异。
混合性RCC和ccRCC在衰减和强化程度上无统计学差异。嗜酸细胞瘤的衰减和强化程度显著高于其他RCC亚型。
虽然混合性RCC的衰减特征与ccRCC没有显著差异,但嗜酸细胞瘤可通过其较高的放射学密度和强化与ccRCC、pRCC、chRCC及混合性RCC区分开来。将嗜酸细胞瘤与这些肿瘤区分开来的能力可能有助于术前选择小肾肿块患者进行保守治疗。